Dietary supplements do not contain pharmaceutical GLP-1 receptor agonists and are not substitutes for prescription treatments
Research into medications designed for long-term or permanent use, or those that create lasting metabolic changes, continues in early stages
CrossRef Association between glucagonlike peptide1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database Tae Hyeon Kim, Kyeongmin Lee, Seoyoung Park, Hanseul Cho, Jaeyu Park, Hyesu Jo, Yejun Son, Soeun Kim, Jiseung Kang, Lee Smith, Masoud Rahmati, Guillaume Fond, Laurent Boyer, Damiano Pizzol, Hayeon Lee, Sang Youl Rhee, Jiyoung Hwang, Hyunji Sang, Dong Keon Diabetes, Obesity and Metabolism.2024
Whether you choose an injectable or explore options like oral tirzepatide, we focus on making the process as transparent and stress-free as possible